Neuromodulation in the treatment of chronic non-malignant pain (from the clinical guidelines on “Surgical treatment of chronic neuropathic pain syndrome”)
Abstract Less effectiveness of conventional treatment for chronic pain syndromes is one of the most frequent indications for neurosurgical methods. In medical literature and medical legislation of Russia there are no official clinical guidelines, regulating the use of neurosurgical treatment for non-malignant chronic pain. Particularly, neurostimulation methods (peripheral nerve stimulation, deep brain stimulation, spinal cord stimulation, motor cortex stimulation) are approved only for typical neuropathic pain syndromes. At the same time such methods like occipital nerve stimulation, subthalamic stimulation, sacral nerve root stimulation, are not included in the official recommendations on the treatment for such syndromes like chronic essential headache (chronic cluster headache, chronic migraine) and chronic pelvic pain. This publication is the project of Russian official recommendations for the use of surgical neuromodulation in the treatment of chronic non-malignant pain syndromes. Common methods and types of surgical neuromodulation are considered. Indications, contraindications and patient selection criteria are described for each neuromodulation method.
Keywords:chronic pain, non- malignant pain, surgical treatment, recommendations, neurostimulation, destructive procedures, intrathecal drug delivery
Clin. Experiment. Surg. Petrovsky J. 2016. № 3. Р. 74–88.
Received: 20.06.2016. Accepted: 15.07.2016.
References
1. Yakhno N.N., Kukushkin M.L., Danilov A.B., Amelin A.V., Davydov O.S., Kulikov S.M. Results of Russian Epidemiologic stady of neuropathic pain prevalence, causes and clical characteristics in the population of ambulatory patients, consulting neurologist. Rossiyskiy zhurnal boli [Russian Journal of Pain]. 2008; Vol. 3 (20): 24–32. (in Russian)
2. Alekseev V.V., Amelin A.V., Davydov O.S., Danilov A.B., Dreval O.N., Shabalov V.A., Isagulyan E.D., Kukushkin M.L., Pavlenko S.S., Strokov I.A., Yakhno N.N. Guidelines for the diagnosis and treatment of neuropathic pain. Moscow: RAMS, 2008: 32 p. (in Russian)
3. Cruccu G., Sommer C., Anand P., Attal N., Baron R., Garcia- Larrea L., Haanpaa M., Jensena T. S., Serraa J., Treedek R.-D. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol. 2010. Vol. 17: 1010–18. doi:10.1111/j.1468- 1331.2010.02969.x.
4. Dworkin R.H., O’Connor A.B., Kent J., Mackey S.C., Raja S.N., Stacey B.R., Levy R.M., Backonja M., Baronh R., Harke H., Loeser J.D., Treede R.-D., Turk D.C., Wells C.D. Interventional management of neuropathic pain: NeuPSIG recommendations. Pain. 2013; 154 (11): 2249–2261. doi:10.1016/j.pain.2013.06.004.
5. Hansson P.T., Attal N., Baron R., Cruccu G. Toward a definition of pharmacoresistant neuropathic pain. Eur. J. Pain. 2009; Vol. 13: 439–40.
6. Torrance N., Ferguson J.A, Afolabi E., Bennett M.I., Serpell M.G., Dunn K.M., Smith B.H. Neuropathic pain in the community: More under-treated than refractory? Pain. 2013; Vol. 154: 690–9. doi: 10.1016/j.pain.2012.12.022.
7. Rasu R.S., Vouthy K., Crowl A.N., Stegeman A.E., Fikru B., Bawa W.A., Knell M.E. Cost of pain medication to treat adult patients with nonmalignant chronic pain in the United States. J. Manag. Care Spec. Pharm. 2014; Vol. 20 (9): 921–8.
8. Gybels J., Erdine S., Maeyaert J., Meyerson B., Van Buyten J.-P., et al. (EFIC) Neuromodulation of Pain / A consensus statement prepared in Brussels 16–18 January 1998 by the following Task Force of the European Federation of IASP Chapters. Eur J Pain. 1998; Vol. 2: 203–9.
9. Isagulyan E.D., Shabalov V.A. Surgical treatment of neuro- pathic pain syndromes. Part I. Neurosurgery [Neyrohirurgiya]. 2009; Vol. 2: 5–12. (in Russian)
10. Isagulyan E.D., Shabalov V.A. Neurostimulation methods in the treatment of pain. Manage Pain. 2014; 4: 48-54.
11. Churyukanov M.V., Dorokhov E.V. Pharmacoresistant neuropathic pain. Rossiyskiy zhurnal boli [Russian Journal of Pain]. 2013; Vol. 3 (40): 44–7. (in Russian)
12. Cruccu G., Aziz T.Z., Garcia-Larrea L., Hansson P., Jensen T.S., Lefaucheur J.-P., Simpson B.A., Taylor R.S. EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol. 2007; Vol. 14: 952–70. doi:10.1111/j.1468-1331.2007.01916.x.
13. Reverberi C., Dario A., Barolat G., Zuccon G. Using peripheral nerve stimulation (PNS) to treat neuropathic pain: a clinical series. Neuromodulation. 2014; Vol. 17 (8): 777–83. doi: 10.1111/ner.12157.
14. Petersen E.A., Slavin K.V. Peripheral nerve/field stimulation for chronic pain. Neurosurg Clin North Am. 2014; Vol. 25 (4): 789– 97. doi: 10.1016/j.nec.2014.07.003.
15. Kloimstein H., Likar R., Kern M., Neuhold J., Cada M., Loinig N., Ilias W., Freundl B., Binder H., Wolf A., Dorn C., Mozes-Balla E.M., Stein R., Lappe I., Sator-Katzenschlager S. Peripheral nerve field stimulation (PNFS) in chronic low back pain: a prospective multicenter study. Neuromodulation. 2014; Vol. 17 (2): 180–7. doi: 10.1111/ner.12139.
16. Lipov E.G. Hybrid neurostimulator: simultaneous use of spinal cord and peripheral nerve field stimulation to treat low back and leg pain. Prog Neurol Surg. 2011; Vol. 24: 147–55. doi: 10.1159/000323047.
17. Isagulyan E.D., Shabalov V.A. Chronic spinal cord electrostimulation in the treatment of failed back surgery syndrome. Khirurgiya pozvonochnika [Spine Surgery]. 2014; Vol. 4: 41–8. (in Russian)
18. Wolter T. Spinal cord stimulation for neuropathic pain: current perspectives. J Pain Res. 2014; Vol. 7: 651–63. doi: 0.2147/ JPR.S37589.
19. Safin A.V., Bobrovskaya A.N., Isagulyan E.D., Durov O.V., Larin A.I. Experience of chronic electrostimulation of sacral plexus for the treatment of chronic neurogenic pelvic pain. Klinicheskaya praktika [Clinical Practice]. 2013; Vol. 1 (13): 31–6. (in Russian)
20. Valovska A., Peccora C.D., Philip C.N., Kaye A.D., Urman R.D. Sacral neuromodulation as a treatment for pudendal neuralgia. Pain Physician. 2014; Vol. 17 (5): E645–50.
21. Peters K.M. Neuromodulation for the treatment of refractory interstitial cystitis. Rev Urol. 2002; Vol.4 Suppl. 1: 36–43.
22. Tirlapur S.A.,Vlismas A., Ball E., Khan K.S. Nervestimulation for chronic pelvic pain and bladder pain syndrome: a systematic review. Acta Obstet Gynecol Scand. 2013; Vol. 92 (8): 881–7. doi: 10.1111/aogs.12184.
23. Norderval S., Rydningen M., Lindsetmo R.O., Lein D., Vonen B. Sacral nerve stimulation. Tidsskr Nor Laegeforen. 2011; Vol. 131 (12): 1190–3. doi: 10.4045/tidsskr.10.1417.
24. Kim J.H., Hong J.C., Kim M.S., Kim S.H. Sacral nerve stimulation for treatment of intractable pain associated with cauda equina syndrome. Journal of Korean Neurosurgical Society. 2010; Vol. 47 (6): 473–6. doi: 10.3340/jkns.2010.47.6.473.
25. Sukul V.V., Slavin K.V. Deep Brain and Motor Cortex Stimulation. Curr Pain Headache Rep. 2014; Vol. 18 (7): 427. doi: 10.1007/s11916-014-0427-2.
26. Nguyen J.P., Nizard J., Keravel Y., Lefaucheur J,P. (2011). Invasive brain stimulation for the treatment of neuropathic pain. Nature Reviews Neurology. 2011; 7(12): 699-709. doi: 10.1038/ nrneurol.2011.138.
27. Nguyen J.P., Velasco F., Brugieres P., Velasco M., Keravel Y., Boleaga B., Brito F., Lefaucheur JP. Treatment of chronic neuropathic pain by motor cortex stimulation: results of a bicentric controlled crossover trial. Brain Stimul. 2008; Vol. 1 (2): 89–96. doi: 10.1016/ j.brs.2008.03.007.
28. Velasco F., Arguelles C., Carrillo-Ruiz J.D., Castro G., Velas- co A.L., Jimеnez F., Velasco M. Efficacy of motor cortex stimulation in the treatment of neuropathic pain: a randomised double-blind trial. J. Neurosurg. 2008; Vol. 108 (4): 698–706. doi: 10.3171/ JNS/2008/108/4/0698.
29. Isagulyan E.D., Tomsky A.A., Dekopov A.V., Salova E.M., Troshina E.M., Dorokhov E.V., Shabalov Results of motor cortex stimulation in the treatment of chronic pain syndromes. Questions of Neurosurgery. 2015; Vol. 79 (6): 46–59; discussion: 59–60 (in Russian). PMID: 26977794.
30. Lima M.C., Fregni F. Motor cortex stimulation for chronic pain: systematic review and meta-analysis of the literature. Neurology. 2008; Vol. 70 (24): 2329–37. doi: 10.1212/01. wnl.0000314649.38527.93.
31. Fontaine D., Hamani C., Lozano A. Efficacy and safety of motor cortex stimulation for chronic neuropathic pain: critical review of the literature. J Neurosurg. 2009; Vol. 110 (2): 251–6. doi: 10.3171/2008.6.17602.
32. Deer T., Winkelmuller W., Erdine S., Bedder M., Burchiel K. Intrathecal therapy for cancer and nonmalignant pain: patient selection and patient management. Neuromodulation. 1999; Vol. 2 (2): 55–66.
33. Smith T.J., Staats P.S., Deer T., Stearns L.J., Rauck R.L., Boortz-Marx R.L., Buchser E., Catalа E., Bryce D.A., Coyne P.J., Pool G.E.; Implantable Drug Delivery Systems Study Group. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol. 2002; Vol. 20 (19): 4040–9.
34. Smith H.S., Deer T.R., Staats P.S., Singh V., Sehgal N., Cordner H. Intrathecal drug delivery. Pain Physician. 2008; Vol. 11 (2 Suppl): 89–104.
35. The British Pain Society. Intrathecal drug delivery for the management of pain and spasticity in adults; recommendations for best clinical practice, www.britishpainsociety.org. Доступно по ссылке: www.britishpainsociety.org/book_ittd_main.pdf (accessed 5 February 2012).
36. DeerT.R.,PragerJ.,LevyR.,RathmellJ.,BuchserE.,BurtonA., Caraway D., Cousins M., De Andres J., Diwan S., Erdek M., Grigsby E., Huntoon M., Jacobs M.S., Kim P., Kumar K., Leong M., Liem L., Mc-
Dowell G.C. 2nd, Panchal S,. Rauck R., Saulino M., Sitzman B.T., Staats P., Stanton-Hicks M., Stearns L., Wallace M., Willis K.D., Witt W., Yaksh T., Mekhail N. Polyanalgesic Consensus Conference 2012: recommendations for the management of pain by intra- thecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation. 2012; Vol. 15 (5): 436–64. doi: 10.1111/j.1525-1403.2012.00476.x.
37. Smith H.S., Deer T.R. Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain. Ther Clin Risk Manag. 2009; Vol. 5 (3): 521–34.
38. Farquhar-Smith P. Neuraxial (epidural and intrathecal) infusions I: Anatomy and commonly used drugs: mode of action, pharmacokinetics, side effects and evidence base for effectiveness. In: Hester J., Sykes N. and Peat S. (eds) Interventional pain control in cancer pain management. Oxford: Oxford University Press, 2011: 58–81.
39. Ackerman L.L., Follett K.A., Rosenquist R.W. Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine/opioid combinations. J Pain Symptom Manage. 2003; Vol. 26 (1): 668–77.
40. Dreval O.N., Akatov O.V., Krivitskaya G.N., Ryabykin M.G. Pathogenetic basis for dorsal root entry zone destruction for the treatment of pain. Rossiyskiy zhurnal boli [Russian Journal of Pain]. 2003; Vol. 1 (1): 34–7. (in Russian)
41. Cetas J.S, Saedi T., Burchiel K.J. Destructive procedures for the treatment of nonmalignant pain: a structured literature review. J Neurosurg. 2008; Vol. 109 (3): 389–404. doi: 10.3171/ JNS/2008/109/9/0389. Review.
42. Chetty S., Baalbergen E., Bhigjee A.I., Kamerman P., Ouma J., Raath R., Raff M., Salduker S; South African Expert Panel. Clinical practice guidelines for management of neuropathic pain: expert panel recommendations for South Africa. South Afr Med J. 2012; Vol. 102 (5): 312–25.
43. Menon J.P. Intracranial ablative procedures for the treatment of chronic pain. Neurosurg Clin North Am. 2014; Vol. 25 (4): 663–70. doi: 10.1016/j.nec.2014.06.003.